Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Quetiapine Fumarate 200 mg tablets vs SEROQUEL 200 mg in healthy Thai volunteers under fasting conditions
TCTR20220801008Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of quetiapine (2 arms), sponsored by Bio-innova. Planned start Oct 2022; status: not yet recruiting.
02
Drugs
quetiapine
Beyond the preview
Go deeper on TCTR20220801008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220801008.